Results 201 to 210 of about 8,268,208 (290)

The overlooked biochemical pathway: how insulin resistance (HOMA-IR) modulates "metabolic masking" of prostate-specific antigen separately from body mass index. [PDF]

Int Urol Nephrol
Eren MT, Özveri H.
europepmc   +1 more source

Risk Stratification of Prostate Imaging Reporting and Data System (PI‐RADS 3) Lesions in the Peripheral and Transition Zones Using Clinical and Quantitative MRI Markers

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Prostate Imaging Reporting and Data System (PI‐RADS) 3 lesions often undergo biopsy despite a low positive predictive value (< 25%) for clinically significant prostate cancer (csPCa), defined as International Society of Urological Pathology (ISUP) Grade Group ≥ 2.
Tejinder Kaur, Reve Chahine, Nicole Seiberlich, Hero Hussain, Shane Wells, Vikas Gulani, Yun Jiang   +6 more
wiley   +1 more source

Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review). [PDF]

Mol Med Rep
Li L, Zhang L, Li Z, Chai K, Ren W.
europepmc   +1 more source

Prostate-Specific Antigen [PDF]

, 2020
openaire   +1 more source

Dosimetry, Toxicity and Stability Associated With a Hyaluronic Acid‐Based Prostate‐Rectal Spacing Device During Prostate Radiation Therapy: A Retrospective Comparative Analysis

Journal of Medical Radiation Sciences, EarlyView.
Rectal spacers composed of stabilised hyaluronic acid facilitated a favourable toxicity profile compared to no spacing during prostate radiation therapy. Acute GI toxicity (grade ≥ 1) was lower in the spacer cohort (23.5% vs. 48.0%; odds ratio = 0.33, p = 0.05) with grade ≥ 2 toxicity substantially lower (2.9% vs. 20.0%).
Fadila Najem, Bridget Smith, Sary Chen, Lucinda Wood, Asmaa El‐Heneidy, Lloyd Smyth, Hodo Haxhimolla, Pat Bowden   +7 more
wiley   +1 more source

Fe₃O₄-Au cluster-satellite particles as direct colorimetric reporters in a smartphone-quantified lateral flow immunoassay for prostate-specific antigen. [PDF]

Mikrochim Acta
Marra D, Cavaliere E, Terracciano D, Levorato LL, D'Aponte T, Iannotti V, Gentile F, Velotta R, Ventura BD.   +8 more
europepmc   +1 more source

Molecular theranostics: principles, challenges and controversies

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley   +1 more source

Prostatic Specific Antigen in Prostate Cancer

The International Journal of Biological Markers, 1987
Juan Morote, Alvaro Ruibal
doaj   +1 more source

From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. [PDF]

Transl Oncol
Hamed NW, Elbeljihy HS, Hussin SA, Fouda RM, Oy EK, W Magar R.   +5 more
europepmc   +1 more source

A two‐stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 93-105, March 2025.
This study developed a two‐stage model using radiomics‐based multiparametric MRI and clinical indicators to help identify and grade clinically significant prostate cancer. The model showed promising levels of diagnostic accuracy and predictive performance.
Yuyan Zou, Xuechun Wang, Fen Ma, Xulun Liu, Chunyue Jiao, Zhen Kang, Jingjing Cui, Yang Zhang, Yan Xie, Lei Chen, Ronghua Tian   +10 more
wiley   +1 more source